
EURJMEDRES . BIOMEDCENTRAL . COM {
}
Title:
Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma | European Journal of Medical Research | Full Text
Description:
Background RNA methylation (RM) is a crucial post-translational modification (PTM) that directs epigenetic regulation. It mostly consists of N1-methyladenosine (m1A), 5-methylcytosine (m5C), N3-methylcytidine (m3C), N6-methyladenosine (m6A), and 2′-O-methylation (Nm). The “writers” mainly act as intermediaries between these modifications and associated biological processes. However, little is known about the interactions and potential functions of these RM writers in hepatocellular carcinoma (HCC). Methods The expression properties and genetic alterations of 38 RM writers were assessed in HCC samples from five bioinformatic datasets. Two patterns associated with RM writers were identified using consensus clustering. Then, utilizing differentially expressed genes (DEGs) from different RM subtypes, we built a risk model called RM_Score. Additionally, we investigated the correlation of RM_Score with clinical characteristics, tumor microenvironment (TME) infiltration, molecular subtypes, therapeutic response, immunotherapy effectiveness, and competing endogenous RNA (ceRNA) network. Results RM writers were correlated with TME cell infiltration and prognosis. Cluster_1/2 and gene.cluster_A/B were shown to be capable of distinguishing the HCC patients with poor prognosis after consensus and unsupervised clustering of RNA methylation writers. Additionally, we constructed RNA modification pattern-specific risk model and subdivided the cases into RM_Score high and RM_Score low subgroups. In individual cohorts or merged datasets, the high RM_Score was related to a worse overall survival of HCC patients. RM_Score also exhibited correlations with immune and proliferation related pathways. In response to anti-cancer treatments, the RM_Score had a negative correlation (drug sensitive) with drugs that focused on the MAPK/ERK and metabolism signaling, and a positive correlation (drug resistant) with compounds targeting RKT and PI3K/mTOR signaling pathway. Notably, the RM_Score was connected to the therapeutic effectiveness of PD-L1 blockage, implying that RM writers may be the target of immunotherapy to optimize clinical outcomes. Additionally, a ceRNA network was generated including 2 lncRNAs, 4 miRNAs, and 7 mRNAs that was connected to RM writers. Conclusions We thoroughly investigated the potential functions of RNA methylation writers and established an RM_patterns-based risk model for HCC patients. This study emphasized the critical functions of RM modification in TME infiltration, targeted therapy, and immunotherapy, providing potential targets for HCC.
Website Age:
25 years and 10 months (reg. 1999-08-06).
Matching Content Categories {📚}
- Science
- TV
- Education
Content Management System {📝}
What CMS is eurjmedres.biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Eurjmedres.biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of eurjmedres.biomedcentral.com audience?
🚀 Good Traffic: 50k - 100k visitors per month
Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Eurjmedres.biomedcentral.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Eurjmedres.biomedcentral.com Make? {💰}
Display Ads {🎯}
$690 per month
According to our algorithms, Eurjmedres.biomedcentral.com's monthly online income from display advertising ranges from $462 to $1,271.
Keywords {🔍}
rmscore, writers, rna, hcc, fig, methylation, article, analysis, cancer, modification, patients, google, scholar, immune, expression, cell, table, cluster, high, survival, cas, nsun, additional, tumor, cohort, file, carcinoma, low, hepatocellular, correlation, drug, mutation, clinical, cohorts, liver, mettl, sensitivity, degs, model, pathways, zhang, infiltration, response, immunotherapy, signaling, group, gene, clustering, tme, potential,
Topics {✒️}
cbx3-mediated c-met/akt/mtor axis sum {pc}_{1}+\sum {pc}_{2} hur-ets1-p21/p27 axis m6a-hur-dependent epigenetic silencing account european journal mir-522–3p/socs5 axis generate mrna–mirna–lncrna network pi3k/akt/mtor signaling ube2c-mediated p53 ubiquitination cancer genome atlas kaplan–meier curves demonstrating kaplan–meier curves show activating akt/mtor signaling pi3k/mtor signaling pathway rna methylation-based classifier rm_patterns-based risk model 2′-o-methylation writer fibrillarin fast-growing hepatocellular carcinomas rna methylation-based model anti-pd-l1 blockers crucial post-translational modification interferon α/γ response rna methylation-related genes rm writers-related signature including includes n1-methyladenosine european economic area multi-center clinical cohorts pd-l1 blockade immunotherapy metastatic urothelial carcinoma rna modification profile anti-pd-l1 treatment mirna–mrna interactions overlapped privacy choices/manage cookies bmc bioinformatics rm writer signature rm phenotype-related degs forecast tumor microenvironment a-related gene expression authors scientific editing univariate cox analysis foxo3-mediated autophagy rna methylation phenotype conducted gsva enrichment analysis protein–rna interactions [5 rna methylation modifications post-translational modification rna methylation modification kaplan–meier method rna methylation model rna methylated modification
Schema {🗺️}
WebPage:
mainEntity:
headline:Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma
description:RNA methylation (RM) is a crucial post-translational modification (PTM) that directs epigenetic regulation. It mostly consists of N1-methyladenosine (m1A), 5-methylcytosine (m5C), N3-methylcytidine (m3C), N6-methyladenosine (m6A), and 2′-O-methylation (Nm). The “writers” mainly act as intermediaries between these modifications and associated biological processes. However, little is known about the interactions and potential functions of these RM writers in hepatocellular carcinoma (HCC). The expression properties and genetic alterations of 38 RM writers were assessed in HCC samples from five bioinformatic datasets. Two patterns associated with RM writers were identified using consensus clustering. Then, utilizing differentially expressed genes (DEGs) from different RM subtypes, we built a risk model called RM_Score. Additionally, we investigated the correlation of RM_Score with clinical characteristics, tumor microenvironment (TME) infiltration, molecular subtypes, therapeutic response, immunotherapy effectiveness, and competing endogenous RNA (ceRNA) network. RM writers were correlated with TME cell infiltration and prognosis. Cluster_1/2 and gene.cluster_A/B were shown to be capable of distinguishing the HCC patients with poor prognosis after consensus and unsupervised clustering of RNA methylation writers. Additionally, we constructed RNA modification pattern-specific risk model and subdivided the cases into RM_Score high and RM_Score low subgroups. In individual cohorts or merged datasets, the high RM_Score was related to a worse overall survival of HCC patients. RM_Score also exhibited correlations with immune and proliferation related pathways. In response to anti-cancer treatments, the RM_Score had a negative correlation (drug sensitive) with drugs that focused on the MAPK/ERK and metabolism signaling, and a positive correlation (drug resistant) with compounds targeting RKT and PI3K/mTOR signaling pathway. Notably, the RM_Score was connected to the therapeutic effectiveness of PD-L1 blockage, implying that RM writers may be the target of immunotherapy to optimize clinical outcomes. Additionally, a ceRNA network was generated including 2 lncRNAs, 4 miRNAs, and 7 mRNAs that was connected to RM writers. We thoroughly investigated the potential functions of RNA methylation writers and established an RM_patterns-based risk model for HCC patients. This study emphasized the critical functions of RM modification in TME infiltration, targeted therapy, and immunotherapy, providing potential targets for HCC.
datePublished:2023-01-27T00:00:00Z
dateModified:2023-01-27T00:00:00Z
pageStart:1
pageEnd:15
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s40001-023-01016-7
keywords:
RNA methylation
Writer
Hepatocellular carcinoma
Tumor microenvironment
RM_Score
Drug sensitivity
Immunotherapy
Medicine/Public Health
general
Infectious Diseases
Internal Medicine
Surgery
Oncology
Biomedicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig8_HTML.png
isPartOf:
name:European Journal of Medical Research
issn:
2047-783X
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Jianping Zhang
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Affiliated Hospital of Nanjing University Medical School
address:
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
type:PostalAddress
type:Organization
type:Person
name:Jie Gao
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Affiliated Hospital of Nanjing University Medical School
address:
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
type:PostalAddress
type:Organization
type:Person
name:Mingchao Hu
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
type:Person
name:Shiyu Xu
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
type:Person
name:Chun Cheng
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Wenjie Zheng
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Jie Zhang
affiliation:
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma
description:RNA methylation (RM) is a crucial post-translational modification (PTM) that directs epigenetic regulation. It mostly consists of N1-methyladenosine (m1A), 5-methylcytosine (m5C), N3-methylcytidine (m3C), N6-methyladenosine (m6A), and 2′-O-methylation (Nm). The “writers” mainly act as intermediaries between these modifications and associated biological processes. However, little is known about the interactions and potential functions of these RM writers in hepatocellular carcinoma (HCC). The expression properties and genetic alterations of 38 RM writers were assessed in HCC samples from five bioinformatic datasets. Two patterns associated with RM writers were identified using consensus clustering. Then, utilizing differentially expressed genes (DEGs) from different RM subtypes, we built a risk model called RM_Score. Additionally, we investigated the correlation of RM_Score with clinical characteristics, tumor microenvironment (TME) infiltration, molecular subtypes, therapeutic response, immunotherapy effectiveness, and competing endogenous RNA (ceRNA) network. RM writers were correlated with TME cell infiltration and prognosis. Cluster_1/2 and gene.cluster_A/B were shown to be capable of distinguishing the HCC patients with poor prognosis after consensus and unsupervised clustering of RNA methylation writers. Additionally, we constructed RNA modification pattern-specific risk model and subdivided the cases into RM_Score high and RM_Score low subgroups. In individual cohorts or merged datasets, the high RM_Score was related to a worse overall survival of HCC patients. RM_Score also exhibited correlations with immune and proliferation related pathways. In response to anti-cancer treatments, the RM_Score had a negative correlation (drug sensitive) with drugs that focused on the MAPK/ERK and metabolism signaling, and a positive correlation (drug resistant) with compounds targeting RKT and PI3K/mTOR signaling pathway. Notably, the RM_Score was connected to the therapeutic effectiveness of PD-L1 blockage, implying that RM writers may be the target of immunotherapy to optimize clinical outcomes. Additionally, a ceRNA network was generated including 2 lncRNAs, 4 miRNAs, and 7 mRNAs that was connected to RM writers. We thoroughly investigated the potential functions of RNA methylation writers and established an RM_patterns-based risk model for HCC patients. This study emphasized the critical functions of RM modification in TME infiltration, targeted therapy, and immunotherapy, providing potential targets for HCC.
datePublished:2023-01-27T00:00:00Z
dateModified:2023-01-27T00:00:00Z
pageStart:1
pageEnd:15
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s40001-023-01016-7
keywords:
RNA methylation
Writer
Hepatocellular carcinoma
Tumor microenvironment
RM_Score
Drug sensitivity
Immunotherapy
Medicine/Public Health
general
Infectious Diseases
Internal Medicine
Surgery
Oncology
Biomedicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig6_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig7_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_Fig8_HTML.png
isPartOf:
name:European Journal of Medical Research
issn:
2047-783X
volumeNumber:28
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Jianping Zhang
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Affiliated Hospital of Nanjing University Medical School
address:
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
type:PostalAddress
type:Organization
type:Person
name:Jie Gao
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Affiliated Hospital of Nanjing University Medical School
address:
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
type:PostalAddress
type:Organization
type:Person
name:Mingchao Hu
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
type:Person
name:Shiyu Xu
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
type:Person
name:Chun Cheng
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Wenjie Zheng
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Jie Zhang
affiliation:
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:European Journal of Medical Research
issn:
2047-783X
volumeNumber:28
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Affiliated Hospital of Nanjing University Medical School
address:
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Affiliated Hospital of Nanjing University Medical School
address:
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Jianping Zhang
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Affiliated Hospital of Nanjing University Medical School
address:
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
type:PostalAddress
type:Organization
name:Jie Gao
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Affiliated Hospital of Nanjing University Medical School
address:
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
type:PostalAddress
type:Organization
name:Mingchao Hu
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Shiyu Xu
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Chun Cheng
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
name:Wenjie Zheng
affiliation:
name:Medical School of Nantong University
address:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
name:Jie Zhang
affiliation:
name:Medical School of Nantong University
address:
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Department of Oncology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
name:Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China
External Links {🔗}(137)
- What is the monthly revenue of https://www.biomedcentral.com/privacy-statement?
- What's https://www.biomedcentral.com's gross income?
- How much does https://www.biomedcentral.com/journals generate monthly?
- What's the income generated by https://www.biomedcentral.com/getpublished each month?
- What is the monthly revenue of https://www.biomedcentral.com/about?
- What is the earnings of https://www.biomedcentral.com/account?
- How much does https://submission.nature.com/new-submission/40001/3 generate monthly?
- https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's revenue stream
- How much revenue does https://portal.gdc.cancer.gov/ generate?
- Get to know what's the income of http://research-pub.gene.com/IMvigor210CoreBiologies
- Explore the financials of https://www.gsea-msigdb.org/gsea/index.jsp
- How much does https://cibersort.stanford.edu/ net monthly?
- What's the monthly income of http://www.cancerrxgene.org/downloads?
- How much cash flow does http://mirtarbase.mbc.nctu.edu.tw/php/index.php have monthly?
- How much does http://www.targetscan.org/vert_72/ rake in every month?
- What is the monthly revenue of http://mirdb.org/?
- What is the monthly revenue of https://doi.org/10.1016%2FS0140-6736%2822%2901200-4?
- How much does http://scholar.google.com/scholar_lookup?&title=Hepatocellular%20carcinoma&journal=Lancet&doi=10.1016%2FS0140-6736%2822%2901200-4&volume=400&issue=10360&pages=1345-1362&publication_year=2022&author=Vogel%2CA&author=Meyer%2CT&author=Sapisochin%2CG&author=Salem%2CR&author=Saborowski%2CA bring in each month?
- Find out how much https://doi.org/10.1002/hep.32779 earns monthly
- What's https://doi.org/10.1002%2Fhep.32779's gross income?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Risk%20stratification%20and%20early%20detection%20biomarkers%20for%20precision%20HCC%20screening&journal=Hepatology&doi=10.1002%2Fhep.32779&publication_year=2022&author=Lee%2CYT&author=Fujiwara%2CN&author=Yang%2CJD&author=Hoshida%2CY?
- https://doi.org/10.1038/s41575-022-00704-9's revenue stream
- What are the earnings of https://doi.org/10.1038%2Fs41575-022-00704-9?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Evolving%20therapeutic%20landscape%20of%20advanced%20hepatocellular%20carcinoma&journal=Nat%20Rev%20Gastroenterol%20Hepatol&doi=10.1038%2Fs41575-022-00704-9&publication_year=2022&author=Yang%2CC&author=Zhang%2CH&author=Zhang%2CL&author=Zhu%2CAX&author=Bernards%2CR&author=Qin%2CW?
- How much income is https://doi.org/10.1093%2Fnar%2Fgkq1028 earning monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20RNA%20Modification%20Database%2C%20RNAMDB%3A%202011%20update&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgkq1028&volume=39&issue=Suppl_1&pages=D195-201&publication_year=2011&author=Cantara%2CWA&author=Crain%2CPF&author=Rozenski%2CJ&author=McCloskey%2CJA&author=Harris%2CKA&author=Zhang%2CX earn?
- Get to know what's the income of https://doi.org/10.1074%2Fjbc.H117.798298
- http://scholar.google.com/scholar_lookup?&title=A%20new%20modification%20for%20mammalian%20messenger%20RNA&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.H117.798298&volume=292&issue=35&pages=14704-14705&publication_year=2017&author=Liu%2CF&author=He%2CC's revenue stream
- What is the monthly revenue of https://doi.org/10.1093%2Fnar%2Fgkaa522?
- How profitable is http://scholar.google.com/scholar_lookup?&title=METTL15%20interacts%20with%20the%20assembly%20intermediate%20of%20murine%20mitochondrial%20small%20ribosomal%20subunit%20to%20form%20m4C840%2012S%20rRNA%20residue&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgkaa522&volume=48&issue=14&pages=8022-8034&publication_year=2020&author=Laptev%2CI&author=Shvetsova%2CE&author=Levitskii%2CS&author=Serebryakova%2CM&author=Rubtsova%2CM&author=Zgoda%2CV?
- What's the income of https://doi.org/10.1074%2Fjbc.M117.798298?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Three%20distinct%203-methylcytidine%20%28m%283%29C%29%20methyltransferases%20modify%20tRNA%20and%20mRNA%20in%20mice%20and%20humans&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M117.798298&volume=292&issue=35&pages=14695-14703&publication_year=2017&author=Xu%2CL&author=Liu%2CX&author=Sheng%2CN&author=Oo%2CKS&author=Liang%2CJ&author=Chionh%2CYH bring in?
- What are the earnings of https://link.springer.com/doi/10.1186/s12943-019-1053-8?
- How much does http://scholar.google.com/scholar_lookup?&title=WTAP%20facilitates%20progression%20of%20hepatocellular%20carcinoma%20via%20m6A-HuR-dependent%20epigenetic%20silencing%20of%20ETS1&journal=Mol%20Cancer&doi=10.1186%2Fs12943-019-1053-8&volume=18&issue=1&publication_year=2019&author=Chen%2CY&author=Peng%2CC&author=Chen%2CJ&author=Chen%2CD&author=Yang%2CB&author=He%2CB gross monthly?
- Check the income stats for https://doi.org/10.15252%2Fembj.2019103181
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=RNA%20m%286%29%20A%20methylation%20regulates%20sorafenib%20resistance%20in%20liver%20cancer%20through%20FOXO3-mediated%20autophagy&journal=EMBO%20J&doi=10.15252%2Fembj.2019103181&volume=39&issue=12&publication_year=2020&author=Lin%2CZ&author=Niu%2CY&author=Wan%2CA&author=Chen%2CD&author=Liang%2CH&author=Chen%2CX?
- What's https://doi.org/10.2147%2FCMAR.S286275's gross income?
- How much profit does http://scholar.google.com/scholar_lookup?&title=METTL14%20inhibits%20hepatocellular%20carcinoma%20metastasis%20through%20regulating%20EGFR%2FPI3K%2FAKT%20signaling%20pathway%20in%20an%20m6A-dependent%20manner&journal=Cancer%20Manag%20Res&doi=10.2147%2FCMAR.S286275&volume=12&pages=13173-13184&publication_year=2020&author=Shi%2CY&author=Zhuang%2CY&author=Zhang%2CJ&author=Chen%2CM&author=Wu%2CS generate?
- Find out how much https://link.springer.com/doi/10.1186/s12943-022-01652-3 earns monthly
- Profit of http://scholar.google.com/scholar_lookup?&title=Targeting%20RNA%20N%286%29-methyladenosine%20modification%3A%20a%20precise%20weapon%20in%20overcoming%20tumor%20immune%20escape&journal=Mol%20Cancer&doi=10.1186%2Fs12943-022-01652-3&volume=21&issue=1&publication_year=2022&author=Li%2CW&author=Hao%2CY&author=Zhang%2CX&author=Xu%2CS&author=Pang%2CD
- How much does https://doi.org/10.3892%2Fol.2020.12353 bring in each month?
- How much income does http://scholar.google.com/scholar_lookup?&title=Increased%20fibrillarin%20expression%20is%20associated%20with%20tumor%20progression%20and%20an%20unfavorable%20prognosis%20in%20hepatocellular%20carcinoma&journal=Oncol%20Lett&doi=10.3892%2Fol.2020.12353&volume=21&issue=2&publication_year=2021&author=Zhang%2CJ&author=Yang%2CG&author=Li%2CQ&author=Xie%2CF have?
- How much profit does https://doi.org/10.1038%2Fs41467-021-26718-6 make?
- How much does http://scholar.google.com/scholar_lookup?&title=N%281%29-methyladenosine%20methylation%20in%20tRNA%20drives%20liver%20tumourigenesis%20by%20regulating%20cholesterol%20metabolism&journal=Nat%20Commun&doi=10.1038%2Fs41467-021-26718-6&volume=12&issue=1&publication_year=2021&author=Wang%2CY&author=Wang%2CJ&author=Li%2CX&author=Xiong%2CX&author=Wang%2CJ&author=Zhou%2CZ bring in each month?
- What's https://doi.org/10.1093%2Fnar%2Fgky029's gross income?
- http://scholar.google.com/scholar_lookup?&title=Positive-sense%20RNA%20viruses%20reveal%20the%20complexity%20and%20dynamics%20of%20the%20cellular%20and%20viral%20epitranscriptomes%20during%20infection&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgky029&volume=46&issue=11&pages=5776-5791&publication_year=2018&author=McIntyre%2CW&author=Netzband%2CR&author=Bonenfant%2CG&author=Biegel%2CJM&author=Miller%2CC&author=Fuchs%2CG's revenue stream
- How much cash flow does https://doi.org/10.3389%2Ffimmu.2022.955848 have monthly?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Comprehensive%20analysis%20of%20m%286%29A%2Fm%285%29C%2Fm%281%29A-related%20gene%20expression%2C%20immune%20infiltration%2C%20and%20sensitivity%20of%20antineoplastic%20drugs%20in%20glioma&journal=Front%20Immunol&doi=10.3389%2Ffimmu.2022.955848&volume=13&publication_year=2022&author=Zhao%2CK&author=Li%2CW&author=Yang%2CY&author=Hu%2CX&author=Dai%2CY&author=Huang%2CM is on a monthly basis
- Revenue of https://link.springer.com/doi/10.1186/s12943-021-01322-w
- What's http://scholar.google.com/scholar_lookup?&title=Cross-talk%20of%20four%20types%20of%20RNA%20modification%20writers%20defines%20tumor%20microenvironment%20and%20pharmacogenomic%20landscape%20in%20colorectal%20cancer&journal=Mol%20Cancer&doi=10.1186%2Fs12943-021-01322-w&volume=20&issue=1&publication_year=2021&author=Chen%2CH&author=Yao%2CJ&author=Bao%2CR&author=Dong%2CY&author=Zhang%2CT&author=Du%2CY's gross income?
- Earnings of https://doi.org/10.1002%2F1878-0261.12153
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Tumor-adjacent%20tissue%20co-expression%20profile%20analysis%20reveals%20pro-oncogenic%20ribosomal%20gene%20signature%20for%20prognosis%20of%20resectable%20hepatocellular%20carcinoma&journal=Mol%20Oncol&doi=10.1002%2F1878-0261.12153&volume=12&issue=1&pages=89-113&publication_year=2018&author=Grinchuk%2COV&author=Yenamandra%2CSP&author=Iyer%2CR&author=Singh%2CM&author=Lee%2CHK&author=Lim%2CKH?
- What's the monthly income of https://doi.org/10.1136%2Fgutjnl-2014-308483?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Neoangiogenesis-related%20genes%20are%20hallmarks%20of%20fast-growing%20hepatocellular%20carcinomas%20and%20worst%20survival.%20Results%20from%20a%20prospective%20study&journal=Gut&doi=10.1136%2Fgutjnl-2014-308483&volume=65&issue=5&pages=861-869&publication_year=2016&author=Villa%2CE&author=Critelli%2CR&author=Lei%2CB&author=Marzocchi%2CG&author=Camma%2CC&author=Giannelli%2CG?
- What are the total earnings of https://doi.org/10.1038%2Fnature25501?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=TGFbeta%20attenuates%20tumour%20response%20to%20PD-L1%20blockade%20by%20contributing%20to%20exclusion%20of%20T%20cells&journal=Nature&doi=10.1038%2Fnature25501&volume=554&issue=7693&pages=544-548&publication_year=2018&author=Mariathasan%2CS&author=Turley%2CSJ&author=Nickles%2CD&author=Castiglioni%2CA&author=Yuen%2CK&author=Wang%2CY each month?
- What are the earnings of https://doi.org/10.1016%2FS0140-6736%2816%2932455-2?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Atezolizumab%20as%20first-line%20treatment%20in%20cisplatin-ineligible%20patients%20with%20locally%20advanced%20and%20metastatic%20urothelial%20carcinoma%3A%20a%20single-arm%2C%20multicentre%2C%20phase%202%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2816%2932455-2&volume=389&issue=10064&pages=67-76&publication_year=2017&author=Balar%2CAV&author=Galsky%2CMD&author=Rosenberg%2CJE&author=Powles%2CT&author=Petrylak%2CDP&author=Bellmunt%2CJ earns monthly
- What's the monthly income of https://link.springer.com/doi/10.1186/1471-2105-14-7?
- http://scholar.google.com/scholar_lookup?&title=GSVA%3A%20gene%20set%20variation%20analysis%20for%20microarray%20and%20RNA-seq%20data&journal=BMC%20Bioinformatics&doi=10.1186%2F1471-2105-14-7&volume=14&publication_year=2013&author=Hanzelmann%2CS&author=Castelo%2CR&author=Guinney%2CJ's total income per month
- How much cash flow does https://doi.org/10.1016%2Fj.molcel.2022.05.029 have monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Hidden%20codes%20in%20mRNA%3A%20Control%20of%20gene%20expression%20by%20m%286%29A&journal=Mol%20Cell&doi=10.1016%2Fj.molcel.2022.05.029&volume=82&issue=12&pages=2236-2251&publication_year=2022&author=Murakami%2CS&author=Jaffrey%2CSR net monthly?
- How profitable is https://doi.org/10.1038%2Fs41576-022-00456-x?
- http://scholar.google.com/scholar_lookup?&title=Means%2C%20mechanisms%20and%20consequences%20of%20adenine%20methylation%20in%20DNA&journal=Nat%20Rev%20Genet&doi=10.1038%2Fs41576-022-00456-x&volume=23&issue=7&pages=411-428&publication_year=2022&author=Boulias%2CK&author=Greer%2CEL income
- Learn how profitable https://link.springer.com/doi/10.1186/s12943-022-01500-4 is on a monthly basis
- What's http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20m6A%20RNA%20methylation%20in%20cancer%20metabolism&journal=Mol%20Cancer&doi=10.1186%2Fs12943-022-01500-4&volume=21&issue=1&publication_year=2022&author=An%2CY&author=Duan%2CH's gross income?
- Get to know https://link.springer.com/doi/10.1186/s12943-022-01619-4's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=CircGPR137B%2FmiR-4739%2FFTO%20feedback%20loop%20suppresses%20tumorigenesis%20and%20metastasis%20of%20hepatocellular%20carcinoma&journal=Mol%20Cancer&doi=10.1186%2Fs12943-022-01619-4&volume=21&issue=1&publication_year=2022&author=Liu%2CL&author=Gu%2CM&author=Ma%2CJ&author=Wang%2CY&author=Li%2CM&author=Wang%2CH rake in every month?
- What's the financial gain of https://link.springer.com/doi/10.1186/s11658-022-00342-8?
- Earnings of http://scholar.google.com/scholar_lookup?&title=METTL16%20promotes%20hepatocellular%20carcinoma%20progression%20through%20downregulating%20RAB11B-AS1%20in%20an%20m%286%29A-dependent%20manner&journal=Cell%20Mol%20Biol%20Lett&doi=10.1186%2Fs11658-022-00342-8&volume=27&issue=1&publication_year=2022&author=Dai%2CYZ&author=Liu%2CYD&author=Li%2CJ&author=Chen%2CMT&author=Huang%2CM&author=Wang%2CF
- Discover the revenue of https://doi.org/10.1016%2Fj.cell.2017.05.046
- http://scholar.google.com/scholar_lookup?&title=Comprehensive%20and%20integrative%20genomic%20characterization%20of%20hepatocellular%20carcinoma&journal=Cell&doi=10.1016%2Fj.cell.2017.05.046&volume=169&issue=7&pages=1327-1341%20e1323&publication_year=2017 income
- https://link.springer.com/doi/10.1186/s13578-021-00555-y's revenue stream
- Profit of http://scholar.google.com/scholar_lookup?&title=DNA%20primase%20subunit%201%20deteriorated%20progression%20of%20hepatocellular%20carcinoma%20by%20activating%20AKT%2FmTOR%20signaling%20and%20UBE2C-mediated%20P53%20ubiquitination&journal=Cell%20Biosci&doi=10.1186%2Fs13578-021-00555-y&volume=11&issue=1&publication_year=2021&author=Zhu%2CM&author=Wu%2CM&author=Bian%2CS&author=Song%2CQ&author=Xiao%2CM&author=Huang%2CH
- How much does https://doi.org/10.1002/cac2.12345 bring in each month?
- How much cash flow does https://doi.org/10.1002%2Fcac2.12345 have monthly?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Tumor-associated%20macrophages%20in%20liver%20cancer%3A%20from%20mechanisms%20to%20therapy&journal=Cancer%20Commun%20%28Lond%29.&doi=10.1002%2Fcac2.12345&publication_year=2022&author=Cheng%2CK&author=Cai%2CN&author=Zhu%2CJ&author=Yang%2CX&author=Liang%2CH&author=Zhang%2CW is on a monthly basis
- How much income does https://doi.org/10.1002/hep.32740 have?
- How much does https://doi.org/10.1002%2Fhep.32740 make?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=The%20liver%20cancer%20immune%20microenvironment%3A%20therapeutic%20implications%20for%20hepatocellular%20carcinoma&journal=Hepatology&doi=10.1002%2Fhep.32740&publication_year=2022&author=Donne%2CR&author=Lujambio%2CA?
- How much money does https://doi.org/10.1038%2Fs41392-020-00264-x make?
- How much income does http://scholar.google.com/scholar_lookup?&title=Targeted%20therapy%20for%20hepatocellular%20carcinoma&journal=Signal%20Transduct%20Target%20Ther&doi=10.1038%2Fs41392-020-00264-x&volume=5&issue=1&publication_year=2020&author=Huang%2CA&author=Yang%2CXR&author=Chung%2CWY&author=Dennison%2CAR&author=Zhou%2CJ have?
- What's the financial outcome of https://doi.org/10.1159%2F000521596?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Systemic%20therapy%20for%20hepatocellular%20carcinoma%3A%20Chinese%20consensus-based%20interdisciplinary%20expert%20statements&journal=Liver%20Cancer&doi=10.1159%2F000521596&volume=11&issue=3&pages=192-208&publication_year=2022&author=Sun%2CY&author=Zhang%2CW&author=Bi%2CX&author=Yang%2CZ&author=Tang%2CY&author=Jiang%2CL
- https://doi.org/10.1038%2Fs41419-020-03247-6 income
- http://scholar.google.com/scholar_lookup?&title=LncRNA%20LINC00998%20inhibits%20the%20malignant%20glioma%20phenotype%20via%20the%20CBX3-mediated%20c-Met%2FAkt%2FmTOR%20axis&journal=Cell%20Death%20Dis&doi=10.1038%2Fs41419-020-03247-6&volume=11&issue=12&publication_year=2020&author=Cai%2CH&author=Yu%2CY&author=Ni%2CX&author=Li%2CC&author=Hu%2CY&author=Wang%2CJ income
- What's the profit of https://doi.org/10.1080/21655979.2021.1996506?
- What's the financial gain of https://doi.org/10.1080%2F21655979.2021.1996506?
- See how much http://scholar.google.com/scholar_lookup?&title=LINC00998%20functions%20as%20a%20novel%20tumor%20suppressor%20in%20acute%20myeloid%20leukemia%20via%20regulating%20the%20ZFP36%20ring%20finger%20protein%2Fmammalian%20target%20of%20rapamycin%20complex%202%20axis&journal=Bioengineered&doi=10.1080%2F21655979.2021.1996506&publication_year=2021&author=Fang%2CX&author=Pan%2CX&author=Mai%2CH&author=Yuan%2CX&author=Liu%2CS&author=Wen%2CF makes per month
- Explore the financials of https://doi.org/10.1016%2Fj.jhep.2020.05.028
- What's the income of http://scholar.google.com/scholar_lookup?&title=Peptide%20SMIM30%20promotes%20HCC%20development%20by%20inducing%20SRC%2FYES1%20membrane%20anchoring%20and%20MAPK%20pathway%20activation&journal=J%20Hepatol&doi=10.1016%2Fj.jhep.2020.05.028&volume=73&issue=5&pages=1155-1169&publication_year=2020&author=Pang%2CY&author=Liu%2CZ&author=Han%2CH&author=Wang%2CB&author=Li%2CW&author=Mao%2CC?
- How much revenue does https://doi.org/10.1080/21655979.2021.1994719 generate?
- What's the income generated by https://doi.org/10.1080%2F21655979.2021.1994719 each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=LncRNA%20DHRS4-AS1%20ameliorates%20hepatocellular%20carcinoma%20by%20suppressing%20proliferation%20and%20promoting%20apoptosis%20via%20miR-522%E2%80%933p%2FSOCS5%20axis&journal=Bioengineered&doi=10.1080%2F21655979.2021.1994719&publication_year=2021&author=Zhou%2CY&author=Li%2CK&author=Zou%2CX&author=Hua%2CZ&author=Wang%2CH&author=Bian%2CW bring in?
- How much profit does https://citation-needed.springer.com/v2/references/10.1186/s40001-023-01016-7?format=refman&flavour=references generate?
- What's the income of https://www.biomedcentral.com/search?query=author%23Jianping%20Zhang?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jianping%20Zhang make?
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jianping%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.biomedcentral.com/search?query=author%23Jie%20Gao gross monthly?
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jie%20Gao?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jie%20Gao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://www.biomedcentral.com/search?query=author%23Mingchao%20Hu's financial summary
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mingchao%20Hu
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mingchao%20Hu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- How much profit does https://www.biomedcentral.com/search?query=author%23Shiyu%20Xu generate?
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shiyu%20Xu have monthly?
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shiyu%20Xu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.biomedcentral.com/search?query=author%23Chun%20Cheng gross monthly?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chun%20Cheng
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chun%20Cheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's https://www.biomedcentral.com/search?query=author%23Wenjie%20Zheng's gross income?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wenjie%20Zheng bring in each month?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wenjie%20Zheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- How much income is https://www.biomedcentral.com/search?query=author%23Jie%20Zhang earning monthly?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jie%20Zhang
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jie%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the financial intake of https://static-content.springer.com/esm/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_MOESM1_ESM.docx?
- Learn about the earnings of https://static-content.springer.com/esm/art%3A10.1186%2Fs40001-023-01016-7/MediaObjects/40001_2023_1016_MOESM2_ESM.xlsx
- What's http://creativecommons.org/licenses/by/4.0/'s gross income?
- How much revenue does http://creativecommons.org/publicdomain/zero/1.0/ bring in?
- Find out how much https://s100.copyright.com/AppDispatchServlet?title=Integrated%20investigation%20of%20the%20clinical%20implications%20and%20targeted%20landscape%20for%20RNA%20methylation%20modifications%20in%20hepatocellular%20carcinoma&author=Jianping%20Zhang%20et%20al&contentID=10.1186%2Fs40001-023-01016-7©right=The%20Author%28s%29&publication=2047-783X&publicationDate=2023-01-27&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 earns monthly
- How much does https://crossmark.crossref.org/dialog/?doi=10.1186/s40001-023-01016-7 gross monthly?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1186/s40001-023-01016-7?format=refman&flavour=citation generate?
- What's the financial gain of https://blogs.biomedcentral.com/?
- How much income is https://www.biomedcentral.com/login earning monthly?
- Discover the revenue of https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022
- How much does https://www.biomedcentral.com/about/policies generate monthly?
- How much money does https://www.biomedcentral.com/accessibility make?
- What's the income generated by https://www.biomedcentral.com/about/press-centre each month?
- How much money does https://support.biomedcentral.com/support/home make?
- What's the profit of https://biomedcentral.typeform.com/to/VLXboo?
- How much does https://www.biomedcentral.com/about/jobs net monthly?
- http://www.weibo.com/biomedcentral's financial summary
- Get to know https://www.biomedcentral.com/terms-and-conditions's earnings
- What's the income generated by https://www.springernature.com/ccpa each month?
- Learn how profitable https://www.biomedcentral.com/cookies is on a monthly basis
- See how much https://www.springernature.com makes per month
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js